At Sunesis, our mission is to develop new medications to treat patients with life-threatening illnesses. Our main focus is the treatment of cancer, and we believe we are making real progress. But we know that treating cancer requires much more than effective medicines. We understand the need for support, information, advocacy, and help that goes along with a diagnosis of cancer, for the patient and his or her loved ones.
Get general information about clinical studies, and learn about Sunesis investigational drugs currently in clinical trial.
Sunesis is developing voreloxin in both AML and ovarian cancer.
Copyright © Sunesis Pharmaceuticals, Inc. 2007. All Rights Reserved.